Federal State Budgetary Institution
National Medical Research Radiological Center
of the Ministry of Health of the Russian Federation

+7 (495) 150-11-22
Weekday 8:00 - 20:00Make an appointmentnmicr.ru

Grants

Implementation of federal target, regional, institutional and other research programs; projects performed under grants in the Federal State Budgetary Institution National Medical Research Radiological Center (NMRRC) of the Ministry of Health of the Russian Federation in 2015.

No Name Responsible officer
1 Agreement No. 14-44-00051 with the Russian Science Foundation on the Program “Performance of the Fundamental Research and Pilot Studies in 2014-2016” within the framework of the Project “Molecular Mechanisms of Solid Adhesion of Circulating Tumor Cells to Vessel Endothelium: Modeling Using Xenograft Models” A.G. Tonevitskiy, Associate Member of the Russian Academy of Sciences (RAS), professor, Head of the Department of Translational Oncology of the P.Hertsen Moscow Oncology-Research Center (MORC), the affiliate of FSBI NMRRC of the Ministry of Health if the Russian Federation; M.Yu. Shkurnikov, K.A. Fomicheva
2 Agreement No. 14.604.21.0132 with the Ministry of Education and Science of the Russian Federation under the Federal Target-Oriented Program “Research and Development in Priority Areas of Development of the Scientific-Technological Complex of Russia for 2014-2020”, the Project “Development of Bio-Inspired Nanostructure Functionally Oriented Materials Adapted for the Prototyping Technology, for Substitution of Osseochondrous Defects” N.S. Sergeeva, professor, Doctor of Medicine, Head of the Department of Efficiency Prognosis of Conservative Treatment of the P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; I.K. Sviridova; N.V. Marshutina; V.A. Kirsanova; and Ya.D. Shanskiy
3 Contract No. НК 13-03-12127/15 with the Russian Foundation for Basic Research (RFBR), Project No. 13-03-12127 "Studies of Physical, Chemical and Biological Peculiarities of the Skeleton of Aqua Cultures of Scleractinic Corals, Compositions Containing Polymers and Tissue-Engineered Structures with MMSC, Based on them, for Reconstruction of the Bone Defects" N.S. Sergeeva, professor, Doctor of Medicine, Head of the Department of Efficiency Prognosis of Conservative Treatment of the P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; I.K. Sviridova; V.A. Kirsanova; and Ya.D. Shans
4 Contract No. НК 13-04-40174-Н/15 with RFBR, Project No. 13-04-40174-Н "Development of the Principles of Objective Preclinical Study of the New Antitumor Gene Therapy Medications, Combining the Intra-Tumor Development of Diffusing Toxins and Stimulation of the Organism’s Immune Response" R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of the P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; and T.N. Andreeva
5 Contract on Research and Development No. 2/14 with the Federal Budgetary Research Institution the Central Scientific-Research Institute of Epidemiology of the Federal Service for Surveillance Consumer Rights Protection and Human Wellbeing of the Russian Federation, necessary for the performance by the Client of the State Contract No. 13411.1008799.13.219, signed with the Ministry of Industry and Trade of the Russian Federation to carry out R&D on "Preclinical Studies of the Combined Gene-Therapeutic Medication for the HIV infection treatment", within the framework of Federal Target-Oriented Program "Development of the Pharmaceutical and Medical Industry of the Russian Federation for the Period until 2020 and the Future Perspective R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of of the P.Hertsen MORC, being the affiliate of FSBI NMRRCs of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
6 Civil Contract No. 223-15/73-03 Optimizing the Technique of Biopsy Sample Preparation of Malignant Tumors of Human for Drawing the Collection of Cryopreserved Samples for the implementation of the Research Program with the Institute of Molecular Biology of RAS (IMB RAS), required to carry out research within the framework of Grant Agreement No.14.607.21.0067 on implementation of the applied research the Analytical System for Personified Identification of Biomarkers Causing Sensitivity for Oncology Biotherapy, signed between IMB RAS and the Ministry of Education and Science of the Russian Federation B.Ya. Alekseyev, professor, Doctor of Medicine, the Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation
7 Contract No. 14.610.21.0001.06 on implementation of the Research and Experimental Studies Program on Development of the Technology of Obtaining and Methodological Recommendations Concerning the Preclinical Studies of Biomedical Preparations on the Basis of Lysate of Thrombocytes of Humans” as the co-performer of the Agreement signed within the framework of the Federal Target Program Research and Development in Priority Areas of Development of the Scientific-Technological Complex of Russia for 2014-2020” N.S. Sergeeva, professor, Doctor of Medicine, Head of the Department of Efficiency Prognosis of Conservative Treatment of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; I.K. Sviridova; N.V. Marshutina; V.A. Kirsanova; and Ya.D. Shansky
8 Contract No.109 on rendering services for organization and implementation of R&D and experimental surgeries on large laboratory animals with Research and Production Center Amfion, LLC E.V. Filonenko, professor, Doctor of Medicine, Head of the Department of Rehabilitation and Restorative Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation
9 Contract 36/1-13 Execution of Clinical Trials of Radochlorine Medical Preparation for Medical Purposes signed between RADA-PHARMS, LLC within the framework of the clinical trial to be held in accordance with protocol No. 01-RADA-FDT-RShM-2012 Prospective Open Studies of Clinical Efficiency of the Photodynamic Therapy of Tumor and Pretumor Cervical Pathology with Radachlorine® Preparation E.V. Filonenko, professor, Doctor of Medicine, Head of the Department of Rehabilitation and Restorative Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation
10 State Contract No. 14411.2049999.19.100 on R&D Organization and Implementation of Clinical Studies of the Medical Preparation Based on the Mixture of Inert Gases with Oxygen for the Therapy of Chronic Pain Syndrome in Oncology Patients, Code 2.2 Inert Gases 2014, signed with the Ministry of Industry and Trade of the Russian Federation within the framework of Federal Target Program Development of the Pharmaceutical and Medical Industry of the Russian Federation in the Period until 2020 and the Future Perspective G.R. Abuzarova, Doctor of Medicine, Head of the Center of Palliative Aid of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; S.V. Kuznetsov
11 Contract No. 43-03/87 on R&D Studies of the Antitumor Activity and Pharmacokinetics of the Radioactive Pharmaceutical Preparation (RAPP) with Beta-Irradiating Radio Isotope Lutetium-177, signed with FSBI National Research Center “Kurchatov’s Institute” on the basis of the Client’s Grant Agreement No. 14.607.21.0041 with the Ministry of Education and Science of the Russian Federation R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
12 Contract No. НПО-112-2015 on R&D Study of the Effect of Preparations Polyxidonium® and Longidaza® on Tumor Growth and Efficiency of Chemotherapy in Experimental Setting”, signed with SPA Petrovax Farm, LLC R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
13 Contract No. 284/15-Нано on R&D Preclinical Studies of the Medication based on the Derivative of Phthalocyanine, signed with the Federal State Unitary Enterprise State Scientific Center NIOPIK within the framework of the Federal Target-Oriented Program Development of the Pharmaceutical and Medical Industry of the Russian Federation in the Period until 2020 and the Future Perspective, and State Contract No. 14.308.11.0011, entered by and between the Client and the Ministry of Education and Science of the Russian Federation R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
14 Contract No. 2-2015 on R&D Safety Estimation of the Anti-Flu Vaccine: Anti-Flu Trivalent Vaccine for Intramuscular Administration on the basis of Recombinant Pseudo-Adenovirus Particles, expressing Genes of Hemagglutinin of Flu Viruses A and B (hereinafter referred to as the Preparation), signed with Immapharma, LLC R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of P.Hertsen MORC, being the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
15 Contract No.04/15-161 on R&D Preclinical Studies of the Gene-Therapeutic Anti-Tumor Remedy with the Hierarchical Amplification of Expression in Tumor Cells of Enzymes Genes, Synthesizing Inhibitors of DNA Replication in the System in vivo, signed with the Institute of Molecular Genetics of RAS on the basis of the State Contract on implementation of R&D No. 13411.1008799.13.161 R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
16 Contract No. ДКИ15-0301 on R&D Comparative Study of the Anti-Tumor Activity of Preparations Docetaxel Liposomal and Taxoter, signed with Drugs Technology, LLC R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
17 Contact No.5-3/2013 on R&D Performance of Preclinical Studies of the Specific (Anti-Tumor) Pharmacological Activity of the Medication GMDP-A, signed with All-Russia Scientific Center for Biologically Active Substance Safety, OJSC, the co-performer under the State Contract R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
18 Contract 05/12/13-1 on R&D Performance of the Preclinical Studies of Chronic Toxicity of the Anti-Flu Vaccine of the Broad Spectrum of Action on the basis of Recombinant Pseudo-Adenoviral Particles, expressing Genes of Ectodomens of the M2 Protein of the Flue A Virus with the Molecular Adjuvant, the Solution for Intranasal Injection, Dose/0.5 ml (Vaccine М2), NTpharma, LLC R.I. Yakubovskaya, professor, Doctor of Biology, Head of the Department of Modifiers and Protectors of the Antitumor Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; E.R. Nemtsova, O.A. Bezborodova; T.A. Karmakova; A.A. Pankratov; T.N. Andreeva; N.B. Morozova; and E.A. Plotnikova
19 Contract No.4/2015 on R&D Performance of the Multi-Center Trial of the Developed Technique, signed with NPF BioClinicum, LLC on the basis of Grant Agreement No. 14.579.21.0018 and the contract on further use of results of the Research Program within the framework of implementation of the Federal Target Program Research and Development in Priority Areas of Development of the Scientific-Technological Complex of Russia in 2014-2020" A.G. Tonevitsky, Associate Member of RAS, professor, Doctor of Biology, Head of the Department for Translational Oncology of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; K.A. Fomicheva
20 Contract No.НИР-БК-1410-1 on the safety system R&D with Scientific Research and Production Center BioClinicum, LLC to provide the performance of the Agreement No. 14.579.21.0054 within the framework of Step 1.3 of the Federal Target Program Research and Development in Priority Areas of Development of the Scientific-Technological Complex of Russia in 2014-2020" A.G. Tonevitsky, Associate Member of RAS, professor, Doctor of Biology, Head of the Department for Translational Oncology of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; K.A. Fomicheva; M.Yu. Shkurnikov; K.M. Nyushko; Yu.P. Polevaya; K.A. Fomicheva; A.S. Kalpinsky; and M.P. Golovashchenko
21 Contract on R&D with the Federal State Budgetary Research Institution N. Blokhin Russian Cancer Research Center on implementation of the medication clinical trial for medical use of ARANOZA, lyophilized substance for preparation of the solution for intravenous injection 0.5 g (vials) in accord with the Protocol of the Medication Clinical Trial for Medical Use No. A-NEO-03-13 Prospective Open Multi-Center Studies of the Efficiency and Toxicity of the Preparation Aranoza in the Mono-Regime as the First-Line Therapy in Patients with Distributed Neuroendocrine Tumors concerning implementation of the State Contract No.13411.1008799.13.125 within the framework of the Federal Target Program Development of the Pharmaceutical and Medical Industry of the Russian Federation for the period until 2020 and the Future Perspective” L.V. Bolotina, Doctor of Medicine, Head of the Chemotherapy Department of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; A.A. Paichadze, L.A. Kramskaya; A.L. Kornietskaya; T.I. Deshkina; and Yu.P. Polevaya
22 Contract on implementation of clinical trial OGX-011-12 Randomized Studies of the Phase III vs. using Kabazitaxel/Prednisone as Chemotherapy of the Second Line for Male-Patients with Metastatic Prostate Cancer, Resistant to Castration PHARM RESEARCH ASSOCIATES RUSSIA LIMITED (UK) B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; K.M. Nyushko; P.V. Shegai; Yu.P. Polevaya
23 Contract No.03/12-R10 on implementation of the clinical trial (implementation of R&D) under protocol AV-951-09-902 Additional Trial for Patients, who has Participated in the Comparative Studies of the Phase III under Protocol AV-951-09-301 (the Studies of Tovozanib and Sorafenib for Treatment of Renal Cell Carcinoma), PSI, LLC B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; A.S. Kalpinsky; Yu.P. Polevaya
24 Contract (protocol AV-951-09-902) on implementation of the clinical studies on the topic: Multi-Center Open Randomized Comparative Studies of Tivozanib (AV-951) and Sorafenib while Treating Patients with Distributed Renal Cell Carcinoma (Phase III of Clinical Trials)”, PSI, LLC B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; A.S. Kalpinsky; Yu.P. Polevaya
25 Contract on implementation of the clinical trial of the medication for medical use No. 288691001-592i/2011, signed with PPD DEVELOPMENT, LLC (Smolensk) Double-Blind Randomized Placebo-Controlled Studies of the 3rd Phase, Held with the Purpose of Studying Taschinimode of Patients with Metastatic Prostate Cancer, Resistant to Castration" B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; K.M. Nyushko; Yu.P. Polevaya, M.V. Golovashchenko
26 Contract on implementation of clinical trial L000700 IN 309 F0 “Studies of the 3rd Phase with the Purpose of Comparing Vinfulin for iv. Injection in Combination with Methotrexate and Methotrexate Monotherapy of Patients with Recurring or Metastatic Head and Neck Squamous Cell Carcinoma, Earlier Exposed to Chemotherapy with Platinum-Containing Preparations, signed with FRA Pharm Research Associates Russia Limited, Meridian L.V. Bolotina, Doctor of Medicine, Head of the Chemotherapy Department of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; A.A. Paichadze, L.A. Kramskaya; A.L. Kornietskaya; and T.I. Deshkina
27 Clinical Trial Protocol D7913C00074 Diagnostic Study for Determination of the EGFR mutation frequency of Patients from Asia and Russia with Distributed Nonsmall Cells Lung Cancer of the Adenoarcinomic and Nonadenocarcinomic Histological Type, BKT, LLC (AstraZeneca) L.V. Bolotina, Doctor of Medicine, Head of the Chemotherapy Department of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; A.A. Paichadze, L.A. Kramskaya; A.L. Kornietskaya; T.I. Deshkina; and Yu.P. Polevaya
28 Contract No. 290/15-РМП dated 22/06/2015 on implementation of the clinical trial under Protocol No. 02-(ФД-ГЭ)-2014 Controlled Open Study of Diagnostic Efficiency of the Preparation Hexasense ®, the Photosensibilizer for Fluoroscopic Diagnostics of Bladder Cancer, signed with the Federal State Unitary Enterprise State Scientific Center NIOPIK E.V. Filonenko, professor, Doctor of Medicine, Head of the Department of Rehabilitation and Restorative Therapy of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation
29 Contract No.171/i-10 on implementation of the clinical trial under protocol А4061051 "AG -013736 (Axitinib) for Treatment of Metastatic Renal Cell Carcinoma, Company Pfizer B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; and P.V. Shegai
30 Contract for implementation of the clinical trial under protocol: 3066KI-3311-WW Open Randomized Study of Phase 3b for Comparison of the Preparations Bevacezumab (Avastin) Combined with Terserolimus (Toricel) and Bevacezumab (Avastin) Combined with Interferon Alpha (Roferon) as the First-Line Therapy of Patients with Distributed Kidney Cancer. PAREXEL INTERNATIONAL (RUS), LLC B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; M.V. Golovashchenko; and K.M. Nyuhsko
31 Contract on implementation of the clinical trial D081DC00008 Randomized, Double-Blind, Multicenter Study of Phase II Aimed at Assessment of Efficiency, Safety, and Tolerability to Olaparib vs. Placebo when Used as the Supplement to Treatment with Abirateron of Patients with Metastatic, Castration-Resistant Prostate Cancer, Earlier subjected to Chemotherapy Containing Docetaxel. The representation office of Quintiles GezmbH B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; M.V. Golovashchenko; and K.M. Nyuhsko
32 Contract on implementation of the clinical trial No. 279721001-817i/2013 (Protocol BNIT-PRV-301) Double-blind, Randomized Study of the 3rd Phase, Aimed at Assessment of Efficiency of Vaccine PROSTVAC-V/F, used in Combination with or without Granulocitar-IARCophagal Colony-Stimulating Factor (GM-CSF) among Male Patients with Asymptomatic or Minimally Symptomatic Metastatic Prostate Cancer, Resistant to Castration B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; A.S. Kalpinsky; and K.M. Nyuhsko
33 Contract on implementation of the clinical study ARN-509-003 on the topic: SPARTAN: Multicenter, Randomized Double-Blind, Placebo-Controlled Study of Phase III of the ARN-509 Preparation Use among Male Patients with Nonmetastatic Castration-Resistant Prostate Cancer B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation
34 Contract on implementation of the clinical study No. 22/i-08 on purpose of Axitinib (AG-013736) preparation examination under protocol А4061032: Axitinib (АG-013736) as the Second-Line Therapy at Metastatic Renal Cell Carcinoma: an Axial Study, signed with Pfizer International LLC B.Ya. Alekseyev, professor, Doctor of Medicine, Research Deputy General Director of FSBI NMRRC of the Ministry of Health of the Russian Federation; and P.V. Shegai
35 Contract on implementation of the clinical trial SB3-G31-BC Multicenter Randomized Double-Blind Study of Phase III, Performed in Parallel Groups to Compare Efficiency, Safety, Pharmacokinetics and Immunogenicity of SB3 (the Proposed Biological Equivalent of Trastuzumab) and Gerzeptin® among Female Patients with First-Ever Diagnosed Early Stage or Locally Distributed HER2, which is the Positive Cancer of Mammal Gland, within the Neoadjuvant Therapy” L.V. Bolotina, Doctor of Medicine, Head of the Chemotherapy Department of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; A.A. Paichadze, L.A. Kramskaya; A.L. Kornietskaya; and T.I. Deshkina
36 Contract on implementation of the clinical trial ОМВ110928/070518 Comparison of Ofatumumab and Rituximab as Chemoimmunotherapy of Salvation with the Subsequent Autologous Grafting of Stem Cells in case of Recurring or Refractor Diffuse Large B-cell Lymphoma. GlaxoSmithKline Trading, Closed Joint-Stock Company N.G. Tyurina, Candidate of Medicine, Head of the Department of High-Dose Chemotherapy with the Bone Marrow Transplantation Unit of P.Hertsen MORC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; A.M. Chervontseva, and O.A. Pavlova
37 International grant with multilateral participation No. 323310 Estimation of Feasibility of the Prospective Cohort Study on the Territory Adjacent to the Semipalatinsk Testing Ground (SEMI-NUC). The pilot project of the International Agency for Research on Cancer (IARC) of the World Health Organization. The Seventh Framework Program for Nuclear Energy of the European Community. Support. The General Directorate for Research and Innovations (SP5-Euroatom). State registration number НТИИМИ 0361/01/15. V.F. Stepanenko, professor, Doctor of Biology, A.F. Tsyba MRSC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation; V.G. Skvortsov; A.I. Ivannikov, T.V. Kolyzhenkov, I.G. Belukha, E.K. Yaskova, A.D. Petukhov, T.V. Lavrova, D.V. Dubov, and N.G. Selyova
38 Grant of the Russian Foundation for Basic Research No. 14-44-03093 Topic: Development of Estimation Methods of Radiation Risks under Implementation of Radiological Procedures for the Population of the Kaluga Oblast.
V.K. Ivanov, Associate Member of RAS, V.V. Kashcheev, S.Yu. Chekin, M.A. Maksyutov, A.I. Gorsky, N.V. Shchukina, and A.N. Menyailo
39 Development of Groups under Increased Radiation Risk on the basis of the Integrated Analysis of Data of the Unified Chernobyl Nuclear Plant Registry of Russia and Belarus, which Includes Elaborated Estimations of Radiation Risks and Prognosis of Remote Medical Radiological Consequences of the Failure at the Chernobyl Nuclear Plant for the Citizens of Russia and Belarus, who was Affected by Radiation due to the Chernobyl Catastrophe within the framework of the Program of Joint Activities Aimed at Overcoming Consequences of the Chernobyl Catastrophe within the Commonwealth for the period until 2016 in 2015, State Contract K-24-НИР/55-2 dated 30/06/2015 V.K. Ivanov, M.A. Maksyutov, A.I. Gorsky, V.V. Kashcheev, S.Yu. Chekin, O.K. Vlasov, E.V. Kochergina, Z.G. Kruglova, K.A. Tumanov, V.V. Kashcheev, P.V. Kashcheeva, A.N. Menyailo, N.S. Zelenskaya, N.V. Shchukina, A.M. Korelo, E.A. Pryakhin, N.N. Drynova, P.A. Veremeev, V.B. Podleshchuk, and M.V. Sopova
40 Grant of the Russian Science Foundation No.14-15-00826. Implementation of basic research and pilot studies by separate research teams in 2014 – 2016. Topic: Development of Radiation-Epidemiological Methods of Studies of Circulation System Diseases and Estimation of their Contribution to Social and Economic Losses Resulting from Radiation Catastrophes.
V.K. Ivanov, Associate Member of RAS, S.Yu. Chekin, M.A. Maksyutov – Candidate of Technical Sciences, A.I. Gorsky – Candidate of Technical Sciences, N.V. Shchukina, V.V. Kashcheev – Candidate of Biology, A.N. Menyailo – Candidate of Biology; E.V. Kruglova, N.S. Zelenskaya, K.A. Tumanov – Candidate of Biology, O.K. Vlasov – Candidate of Technical Sciences, S.V. Karpenko, A.M. Korelo, E.I. Romashkina, and D.D. Babina
41 Federal Target Program Provision of Nuclear and Radiation Safety for 2008 and for the Period until 2015, Contract No. 2015/168-04 dated May 26, 2015 R&D topic: Development of the Modular Unit for Assessment of Risks Related to Current and Estimated Levels of Radiation Affect of Hazardous Nuclear and Radiation Facilities on the Population, Taking into Account Current Models of the Dose-Effect Dependency”.
V.K. Ivanov, Associate Member of RAS, A.I. Gorksy, M.A. Maksyutov, and A.N. Menyailo
42 Cooperation under the studies of medical consequences of the Chernobyl nuclear catastrophe (CO-CHER), Grant Agreement No. 605302 CO-CHER V.K. Ivanov, Associate Member of RAS, N.G. Seleva, V.V. Kashcheev, M.A. Maksyutov, and A.N. Tumanov
Grant of the Russian Humanitarian Science Foundation No. 15-16-40002a(р) Complex Studies of Stress-Induced and Radiation Factors of Risk of Psychiatric and Behavioral Disorders of the Chernobyl Nuclear Catastrophe Consequences Elimination Team Members, residing in Kaluga Oblast V.K. Ivanov, Associate Member of RAS, V.V. Kashcheev, S. Chekin, N.V. Shchukina, S.V. Karpenko, and S.S. Lovachev
43 Grant of the Russian Science Foundation No.№ 15-15-10013. Implementation of fundamental research and pilot studies with involvement of young researchers (Candidates of Sciences). I.A. Zamulaeva, N.V. Orlova, K.A. Pronyushkina, O.N. Matchuk, N.G. Yabbarov, L.N. Dyakova, E.D. Nikolskaya, and S.A. Makarenko
Topic: Development of the Universal System of Targeted Delivery of Preparations to Tumor Cells on the Basis of Dendrite Polymers and the Protein Vector.
44 Grant of RFBR No.15-34-51039 (contest code: “мол_нр”) - Research projects carried out by young scientists under guidance of the Candidates and Doctors of Science in scientific organizations of the Russian Federation A.N. Osipov, project supervisor (Institute of Chemical Physics of RAS), K.A. Pronyushkina, performer, young researcher from MRSC. Head I.A. Zamulaeva.
Studies of the Synthetic Dimeric Bis-Benzimidazols Action on Stem and Nonstem Tumor Cells.
45 Grant of RFBR No.15-34-10485 (grants for youth). The contest of scientific projects for arrangement of Russian and international scientific conferences E.E. Beketov – Project Supervisor
Topic: The project of conference arrangement for young scientists, dedicated to the memory of Academician A.F. Tsyba, Prospective Areas of Oncology and Radiology
46 Grant of RFBR No.14-00-10078_IR L.P. Zhavoronkov - Project Supervisor
Access to electronic scientific information resources of foreign publishing houses (Springer, Germany; Elsevier, the Netherlands)
47 Grant of RFBR and Department of Science and Technology of the Government of the Republic of India No.15-58-45050 ИНД_a – Implementation of the joint Indian-Russian basic research V.F. Skvortsov, A. Khailov, and other employees of the experimental nuclear medicine laboratory
Topic: Studies of the Stable Paramagnetic Centers Formation in Alanine affected by Alpha, Gamma and Neutron Radiation using the EPR-Spectroscopy method.
48 Sub-contract No. 1483, including the Additional Agreement No.1 with the Dartmund College (Hannover, NH, USA) from July 9, 2014 to July 8, 2015 V.F. Skvortsov and other employees of the experimental nuclear medicine laboratory
Topic: Extraction of Radiation-Induced Signal in Tooth Enamel for in vivo EPR Dosimetry
49 Grant of RFBR No.14-44-03084 р_центра; Topic: Studies of Biological Effects of Secondary Irradiation of Photons and Protons for Modeling of Aurum-Capture Therapy. S.N. Koryakin – project supervisor, employees of the Radiation Biophysics Department
50 Grant of RFBR No.14-44-03072 р_центра T.I. Ivanova – project supervisor. Employees of the molecular and cell radiobiology laboratory; Department of Beam and Combined Methods of Treatment of Gynecological Disorders; Department of Laboratory Diagnosis.
Topic: Polymorphism of Genes and Metabolism of Iron and Lipids at Malignant Tumors of a Female Reproductive System.
51 Foundation for Assistance in Development to Small Innovative Enterprises in Science and Technology – General Client V.A. Revkova – project supervisor, Department of Cell and Experimental Beam Therapy (A.G. Konoplyannikov - Head of the Departmnet).
Grant of the regional contest of youth innovative scientific-and-technical projects in Kaluga Oblast within the framework of the Program: The Participant of the Youth Scientific-Innovative Contest (WIZARD-2014). Area Medicine of Future (sponsoring via the Obninsk Institute of Nuclear Power Engineering of the National Research Nuclear University of Moscow Engineering Physics Institute)
Topic: Complex of Detonation Nano-Diamonds an Salinomycine as the Efficient Preparation for the Antitumor Therapy
52 Grant of the Russian Humanitarian Scientific Foundation in the projects contest in the field of humanities: Central Russia: Past, Present and Future No. 15-16-40011 a(r). I.K. Khvostunov, project supervisor of the laboratory of radiation cytogenetics; Department of Radiosurgical Treatment by Open Radionuclides
Topic: Improvement of the Assessment Technique of Negative Consequence of the Radioactive Iodine Therapy for the Purpose of Impoving the Quality of Life of Patients by Means of Optimizing the Treatment Method for the Patients with Differentiated Thyroid Cancer.
53 Grant of the Russian Humanitarian Scientific Foundation (RHSF) in the projects contest in the field of humanities: Central Russia: Past, Present and Future No. 15-16-40010 a(r). G.P. Zhurakovskaya – project supervisor, employees of the biophysical laboratory
Topic: Synergy of Solar Radiation and Negative Factors of the Technosphere: Social and Medical Aspects.
54 Federal Target Program Development of the Pharmaceutical and Medical Industry of the Russian Federation for the Period until 2020 and the Future Perspective. Contest No. 11. State Contract No. 13411.1008799.13.098 as per June 9, 2013 S.E. Ulyanenko, project supervisor of the A.F. Tsyba’s Department of Radiation Biophysics and MRNC, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation
Topic: Development of the Technology and Organization of the Unit Production for High-Efficient Beam Therapy with the Proton Beam, code “4.3-Протон”
55 Contract No.11/04-НИР dd. 11/04/2011 I.A. Gulidov, project supervisor, Department of the Beam Therapy, Division of Radiation Biophysics
with PROTOM, CJSC
Implementation of clinical tests of the Proton therapeutic integrated unit in Protvino of Moscow Oblast
56 Contract on collaborative studies within the framework of the program of RAS “Fundamental sciences for medicine”, signed with the Institute of Organic Chemistry named after N.D. Zelinsky of the Russian Academy of Sciences, w/no (without budgeting) A.Konoplyannikov, project supervisor, and employees of the Cell and Experimental Beam Therapy Department.
Topic: Studies on Use of the Mesenchymal Stem Cells Activators as the Supplement to the Complex Therapy of Sepsis in the Experimental Animal Setting
57 International agreement with the Erasmus University Medical Center Rotterdam, the Netherlands) Screening of Prostate Cancer in Novokhoper Raion of Voronezh Oblast

O.I. Apolikhin, professor, Doctor of Medicine, Director of the N.A. Lopatkin Scientific and Research Institute of Urology and Intervention Radiology, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation

I.A. Shaderkin, Head of the Division of Regional Urology of the N.A. Lopatkin Scientific-Research Institute of Urology and Intervention Radiology, the affiliate of FSBI NMRRC of the Ministry of Health of the Russian Federation